This is accomplished by: • Adhering to applicable global safety, health and environmental laws, regulations, and standards Conducting risk assessments on hazardous products >1 ton for human health (CMRs) and environmental impacts (PBT, vPvB) associated with their intended use prior to placing on the market Protecting our associates, neighbors and the environment in the communities in which we operate, by understanding the health and environmental impact of our raw materials and products where hey are manufactured or used

MANUFACTURER BOOSTS DISINFECTANT RESISTANCE FOR MEDICAL DEVICE HOUSINGS HIGH PERFORMANCE MEDICAL FORMULATIONS © 2020, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 To learn more about Trilliant HC, contact Avient at +1.844.4AVIENT (1.844.428.4368). Here’s a case in point: A leading manufacturer of medical devices in North America had established a great brand with excellent quality, but wanted to improve the resistance of its PC/ABS equipment housings to this new disinfection protocol.

China has been assessed and certified as meeting the requirements of 麟 ISO 13485:2016 EN ISO 13485:2016 ’骥鑫馨瓤） For the foiowing actratEes Design and manufacture of medical grade thermoplastic elastomers for non-active medical devices and active medical devices 遴；舞蒸；撇蒸 (non-implantable) ：护、：：于b入沙黔娜；舞睡莎：器器舞蟒檬非拟拐称群亘爸竺舀‘。

Smart Materials™ Download the eBook

We are better together through: Keeping Safety First — PolyOne and Clariant are both ACC Responsible Care® companies, and nothing is more important than the health, safety and well-being of our people. We are Avient. 6 BETTER TOGETHER: POLYONE AND CLARIANT COLOR Key Financial Data 2021 Sales $4.8 billion 2021 EBITDA $581 million 87% of EBITDA from specialty applications 2021 PE RF O RM AN CE $80 $85 $0.52 $0.58 Q4 2021 PERFORMANCE 8 Sales Adjusted Operating Income $997 $1,202 + 21% Adjusted EPS + 6% + 12% (in millions) (in millions) $308 $429 $1.93 $3.05 FULL YEAR 2021 PERFORMANCE 9 Sales Adjusted Operating Income $3,783 $4,819 + 27% Adjusted EPS + 39% + 58% (in millions) (in millions) (1) (1) (1) FULL YEAR 2021 SEGMENT PERFORMANCE 10 $2,043 $2,402 SEM Distribution $226 $303 + 18% + 34% $1,110 $1,631 $70 $93 + 47% + 33% $709 $919 $94 $132 + 30% + 40% Full Year 2020 (Pro forma) $3,783 $308 Sustainable Solutions 147 19% 60 Healthcare 143 28% 30 Composites 58 43% 29 Growth in Asia / LATAM 107 21% 26 Other 543 30% 58 Sub-total $4,781 26% $511 Wage Inflation and Overtime (39) Other Supply Chain Costs (15) COVID Response Applications (22) (12) Synergies 44 FX, Incentives, Other Employee Costs 60 (60) Full Year 2021 $4,819 27% $429 FULL YEAR 2021 SALES AND OPERATING INCOME 11 Sales Growth Rate Operating Income$ millions EBITDA 12 Full Year 2020 (Pro forma) $ 457 Demand 135 $ millions CAI: Price / Mix 158 Inflation (120) SEM: Price / Mix 84 Inflation (65) Distribution: Price / Mix 318 Inflation (304) Net Price Benefit 71 Wage Inflation and Overtime (39) Other Supply Chain Costs (15) COVID Response Applications (12) Synergies 44 Incentives, FX, Other Employee Costs (60) Full Year 2021 $ 581 • Demand impact driven by growth in key focus areas: sustainable solutions, healthcare, composites and growth in Asia / LATAM • Price increases more than offset raw material and supply chain impacts FULL YEAR 2021 EBITDA BRIDGE SPECIALTY EBITDA MARGIN EXPANSION 13 (1) 2018-2020 financial information is pro forma to include a full year of Clariant Color business 15.3% 15.2% 16.2% 17.0% 2018 2019 2020 2021 14.8% 15.2% 17.6% 17.8% 2018 2019 2020 2021 SEM • Record margins in 2021 despite unprecedented supply chain challenges • Continued portfolio transformation to high-growth end markets and sustainable solutions • Clariant Color synergy realization • Investments in composites and outdoor high performance applications drove growth and mix improvements • Acquisition of Clariant Color business significantly expanded presence in healthcare, packaging and consumer end markets • Strength of portfolio – double-digit annual EBITDA growth since acquisition • $54 million of synergies realized in 2021 • Acquisition completed on July 1, 2020 for $1.45 billion. Purchase price multiple rapidly declining on strength of business and synergy capture 14 $133 $205 2019PF 2021 14 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.1x 2019PF 2021 2021 w/ Full Synergies 11.9% 16.2% 2019PF 2021 EBITDA Margins CLARIANT COLOR: TRANSFORMATIONAL ACQUISITION (1) Financial information is pro forma to include a full year of Clariant Color business ($ millions) Initial Synergy Estimate 2021 Synergy Realization Total Synergies Expected Administrative $ 18 $ 29 $ 40 Sourcing 24 20 24 Operational 18 5 21 Total Synergies $ 60 $ 54 $ 85 CLARIANT COLOR INTEGRATION & COST SYNERGIES UPDATE 15 • Integration going extremely well: synergy target increased to $85 million at December 9th Investor Day • Relentless focus on guiding principles of safety first, employee collaboration and exceeding customer expectations • Future revenue synergies are not part of these estimates and represent additional growth over the long term SUSTAINABILITY FOR A BETTER TOMORROW • Revenue from sustainable solutions grew 16% in 2021 and expected to grow 8-12% in 2022 as our innovation efforts and collaboration with customers accelerates • Investments centered around innovation and global sustainability megatrends o Enabling a circular economy – Technologies that allow for increased use of post-consumer recycled (PCR) material and improve recyclability of plastics o Light-weighting – Composites and CAI applications to reduce weight and material requirements, which minimize energy and carbon emissions o Eco-Conscious – Health and human safety applications as well as Avient’s alternative materials to replace lead, PVC, halogens, BPA and other less eco-friendly options *Avient Sustainable Solutions definitions aligned with FTC 2012 Guide for the Use of Environmental Marketing Claims (“Green Guides”) **2020 is Pro Forma to include full year of the Clariant Color business 2016 2017 2018 2019 2020PF** 2021 $405M $455M $550M $790M Revenue From Sustainable Solutions* 2016-2021 $915M $340M PEOPLE C U L T U R E I S E V E R Y T H I N G Community Service 7x Safer than Industry Average World-Class Safety Leadership Development Over $16 million raised since 2010 Diversity & Inclusion 17 Q4 2020 $997 $80 Sustainable Solutions 23 12% 8 Healthcare 53 43% 9 Composites 7 22% 2 Growth in Asia / LATAM 14 10% 3 Other 118 23% 2 Sub-total $1,212 22% $104 Wage Inflation and Overtime (11) Other Supply Chain Costs (4) Synergies 9 Incentives, FX, Other Employee Costs (10) (13) Q4 2021 $1,202 21% $85 Q4 2021 SALES AND OPERATING INCOME 18 Sales Growth Rate Operating Income$ millions EBITDA Q4 EBITDA BRIDGE 19 Price increases more than offsets raw material and supply chain impacts Q4 2020 $ 118 Demand - $ millions CAI: Price / Mix 62 Inflation (45) SEM: Price / Mix 25 Inflation (20) Distribution: Price / Mix 114 Inflation (109) Net Price Benefit 27 Wage Inflation and Overtime (11) Other Supply Chain Costs (4) Synergies 9 Incentives, FX, Other Employee Costs (13) Q4 2021 $ 126 Transportation (5)$ Outdoor High Performance (3) Other 8 Total Demand - Q4 2021 SEGMENT PERFORMANCE 20 $526 $581 SEM Distribution $58 $61 + 11% + 6% $305 $425 $18 $22 + 39% + 22% $191 $228 $30 $29 + 19% - 3% 2022 O U TLO O K REVENUE GROWTH DRIVERS Growth Drivers Long-Term Growth Rate 2022E Growth Rate Sustainable Solutions 8–12% 12% Healthcare 8–10% 10% Composites 10% 3% Asia / LATAM 5% 6% Other (GDP growth) 2–3% 2–3% Avient 6.5% 6% 22 Excluding Outdoor High Performance 13% (7.5% excl.

MEDICAL EQUIPMENT MANUFACTURER S U R G I C A L X - R A Y G L A S S E S • Replace lead while providing uniform shielding performance • Radiation shielding up to 140KeV • Improve glasses design • Compliance with Radiation Protection Regulation: Adult eye exposure must be below 20 mSv per calendar year • Conducted extensive testing to ensure comparable and uniform shielding performance • Improved geometric flexibility • Lowered shielding component costs 30-50% by eliminating machining and assembly steps (associated with lead) • Reduced weight of the glasses and enabled a more ergonomic design • Eliminated disposal concerns associated with lead Trilliant™ XR Lead Replacement Thermoplastics KEY REQUIREMENTS WHY AVIENT? https://www.avient.com/products/engineered-polymer-formulations/conductive-signal-radiation-shielding-formulations/trilliant Medical equipment manufacturer

3 Certificate Certified sites according to appendix Scope concentrates and specialty compounds for the Healthcare and Medical device market. Normative basis EN ISO 13485:2016 Medical devices – Quality Management System Page 1 of 3 Appendix of main certificate H61173 Central function Scope Norm / Revision Reg. no.

Trendwatch™ Overcoming 5G Component Challenges (English)

SPECIALTY ENGINEERED MATERIALS FOR HEALTHCARE PRODUCT SELECTION GUIDE Careful consideration must be given to materials used for medical devices and their impact on patient safety. Common applications include medical device overmolds, medical and biopharma tubing, and gaskets and stoppers. MATERIAL DESCRIPTION BASE RESIN Trilliant™ HC2020 Copolyester Trilliant™ HC8910/8920 Polyketone/ABS blend Trilliant™ HC2120 Tritan Trilliant™ HC3120 PC Trilliant™ HC5210 PP Trilliant™ HC6010 PA6 Trilliant™ HC6610 PA66 Trilliant™ GRV-NP-110-W PA12 TRILLIANT™ HC THERMOPLASTICS • Chemically resistant replacement for FR PC/ABS, FR PC/PET & FR COPE, providing UL 94 Yellow Card V-0 flame rating at 1.5 mm, V-1 at 0.75 mm thicknesses for a broad color spectrum • Outperforms PC/ABS, PC/PET and COPE in resistance to common disinfectants • Retains tensile strength after 72-hour exposure to common hospital disinfectants, and shows better long-term chemical resistance as compared to PC blends and COPE • Exhibits good impact and temperature resistance • Available in natural grades, standard medical colors, or custom pre-colored products • Medical device housings • MRI, X-ray, CT scanner components • Surgical instruments such as staplers, dissectors, scissors • Auto-injector pen TRILLIANT™ HC ELECTRICALLY CONDUCTIVE FORMULATIONS • Consistent conductivity ensures repeatable part performance and minimizes failures related to inconsistent electrical conductivity • High flow and easy processing facilitate filling of thin wall parts and multiple cavity tools, which enable faster cycle times and lower per-unit part costs • Superior durability reduces breakage and resultant scrap related costs • Less tendency to flash results in improved appearance and less fluid retention in or on the tip, thus driving greater accuracy and less potential for cross-contamination • High strength produces parts with greater stiffness and warp resistance, again minimizing scrap-related costs • Conductive pipette tips TEST TEMS SPECIFIC GRAVITY MELT FLOW RATE (230OC, 2.16KG) TENSILE FLEXURAL FLEXURAL MODULUS IMPACT STRENGTH NOTCHED, IZOD SURFACE RESISTIVITY Method ASTM D-792 ASTM D-1238 ASTM D-638 ASTM D-790 ASTM D-790 ASTM D-256 ASTM D-257 Unit -- g/10min MPa MPa MPa J/m Ohms/sq.

Health and Safety • Implement appropriate processes and procedures to ensure that human health and safety are at the forefront of your actions. Comply with all applicable environmental, health, safety, and security regulations. Identify and manage risks to human health and the environment during development, transport, use and disposal of your products.